Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Re

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Blood|April 1, 1994
Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cellsM Muzio, F Re, M Sironi, et al.
Cardiovascular & Hematological Disorders Drug Targets|December 6, 2018
Carfilzomib: A Tale of a Heartbreaking Moment: Case Report and Concise Review of the LiteratureW Serra, A Fantin, C Longo, et al.
Oncogene|December 19, 2012
Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancerJ C Montero, A Esparís-Ogando, M F Re-Louhau, et al.
Bone Marrow Transplantation|February 27, 2001
Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cellsD Rondelli, F Re, G Bandini, et al.
Aging Clinical and Experimental Research|April 28, 2017
Increased dabigatran plasma concentration during Ibrutinib treatment: a case of cerebral hemorrhage and successful dabigatran reversal by idarucizumabR Quintavalla, M Lombardi, P Prandoni, et al.
Science (New York, N.Y.)|July 23, 1993
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4F Colotta, F Re, M Muzio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)M Rummel, T M Kim, F Aversa, et al.
BMC Infectious Diseases|April 9, 2020
Assessing Gammapapillomavirus infections of mucosal epithelia with two broad-spectrum PCR protocolsElisa M Bolatti, Lea Hošnjak, Diego Chouhy, et al.
The Journal of Experimental Medicine|April 1, 1996
Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 functionF Re, M Sironi, M Muzio, et al.
Bone Marrow Transplantation|November 18, 1998
Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cellsD Rondelli, D Raspadori, C Anasetti, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Blood|April 1, 1994
Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cellsM Muzio, F Re, M Sironi, et al.
Cardiovascular & Hematological Disorders Drug Targets|December 6, 2018
Carfilzomib: A Tale of a Heartbreaking Moment: Case Report and Concise Review of the LiteratureW Serra, A Fantin, C Longo, et al.
Oncogene|December 19, 2012
Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancerJ C Montero, A Esparís-Ogando, M F Re-Louhau, et al.
Bone Marrow Transplantation|February 27, 2001
Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cellsD Rondelli, F Re, G Bandini, et al.
Aging Clinical and Experimental Research|April 28, 2017
Increased dabigatran plasma concentration during Ibrutinib treatment: a case of cerebral hemorrhage and successful dabigatran reversal by idarucizumabR Quintavalla, M Lombardi, P Prandoni, et al.
Science (New York, N.Y.)|July 23, 1993
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4F Colotta, F Re, M Muzio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)M Rummel, T M Kim, F Aversa, et al.
BMC Infectious Diseases|April 9, 2020
Assessing Gammapapillomavirus infections of mucosal epithelia with two broad-spectrum PCR protocolsElisa M Bolatti, Lea Hošnjak, Diego Chouhy, et al.
The Journal of Experimental Medicine|April 1, 1996
Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 functionF Re, M Sironi, M Muzio, et al.
Bone Marrow Transplantation|November 18, 1998
Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cellsD Rondelli, D Raspadori, C Anasetti, et al.
Pageof 8